Press release
Rising incidences of CVD is accelerating the Global Myocardial Infarction Treatment Market | Market Opportunities and Forecast, 2018-2023 | Major Companies: AstraZeneca PLC, Merck KGaA, Johnson & Johnson, Pfizer, Inc., Novartis International AG, GlaxoSmit
Orion Market Research
A full report of global myocardial infarction treatment market is available at https://www.omrglobal.com/industry-reports/myocardial-infarction-treatment-market/
Furthermore, the global myocardial infarction treatment market is segmented on the basis of type, device, diagnosis, treatment and end-users. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Myocardial Infarction Treatment Market by Type
• ST-Segment Elevation Myocardial Infarction (STEMI) Heart Attacks
• Non-ST Segment Elevation Myocardial Infarction (NSTEMI) Heart Attacks
• Silent Heart Attacks
2. Global Myocardial Infarction Treatment Market by Device
• Left Ventricular Assist Device
• Pacemaker
• Implantable Cardioverter Defibrillator
• Others (Aspiration-Based Catheters)
3. Global Myocardial Infarction Treatment Market by Diagnosis
• Electrocardiography (ECG)
• Chest X-Ray
• Computed Tomography (CT Scan)
• Echocardiography
• Others (Blood Test)
4. Global Myocardial Infarction Treatment Market by Treatment
• Medication
o Analgesics
o Thrombolytic
o Antiplatelet Agents
o Glycoprotein IIb/IIIa Inhibitors
o Others (Adrenergic Blockers)
• Surgery
o Angioplasty
o Bypass Surgery
o Heart Transplant
5. Global Myocardial Infarction Treatment Market by End-Users
• Hospital & Clinics
• Ambulatory Surgical Centers
• Research Institutes
Regions Covered
• North America (the US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)
Company Profiles
• advanceCOR GmbH
• Anthera Pharmaceuticals, Inc.
• AstraZeneca PLC
• Athersys, Inc.
• Bayer AG
• BioVascular, Inc.
• Boehringer Ingelheim International GmbH
• BRISTOL-MYERS SQUIBB Co.
• Caladrius Biosciences, Inc.
• Capricor Therapeutics, Inc.
• CSL Behring
• GlaxoSmithKline PLC
• GNT Pharma Co., Ltd
• Johnson & Johnson
• Merck KGaA
• Mesoblast Ltd.
• Mylan N.V.
• NeuroVive Pharmaceutical AB
• Novartis International AG
• Osiris Therapeutics, Inc.
• Pfizer, Inc.
• PledPharma AB
• Portola Pharmaceuticals, Inc.
• Sandoz International GmbH
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Ventrix, Inc.
For related reports please visit https://www.omrglobal.com/reports-category/medical-devices/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising incidences of CVD is accelerating the Global Myocardial Infarction Treatment Market | Market Opportunities and Forecast, 2018-2023 | Major Companies: AstraZeneca PLC, Merck KGaA, Johnson & Johnson, Pfizer, Inc., Novartis International AG, GlaxoSmit here
News-ID: 1651418 • Views: …
More Releases from Orion Market Research
Anti-Viral Drug Market - Industry Trends and Forecast to 2033
The global antiviral drugs market is projected to grow from USD 50 billion in 2023 to USD 71 billion by 2033, with a compound annual growth rate (CAGR) of 3.73% during the forecast period from 2024 to 2033.
Anti-Viral Drug Market Overview
Antiviral drugs are essential in the treatment and prevention of viral infections, including HIV, hepatitis, influenza, and emerging viral diseases. The market's growth is driven by the increasing…
Tuberculosis Vaccine Market - Industry Trends and Forecast to 2032
The global tuberculosis (TB) vaccine market was valued at approximately USD 63.11 billion in 2023 and is projected to reach USD 88.28 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.38% from 2024 to 2032.
Tuberculosis Vaccine Market Overview
The tuberculosis vaccine market is primarily driven by the Bacillus Calmette-Guérin (BCG) vaccine, which has been the standard preventive measure against TB for decades. Despite its widespread use,…
Favipiravir Market: Emerging Trends and Growth Forecast to 2032
The global Favipiravir market was valued at approximately USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2032.
Favipiravir Market Overview
Favipiravir, an antiviral medication initially developed for influenza, gained prominence during the COVID-19 pandemic due to its potential efficacy against the virus. The market's growth is driven by the increasing prevalence…
Beauty Tools Market Overview: Growth, Share, Value, Size, and Scope
The global beauty tools market was valued at approximately USD 68.9 billion in 2023 and is projected to reach USD 99.78 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2032.
Beauty Tools Market Overview
The beauty tools market encompasses a wide range of products, including hair care tools, razors, trimmers, brushes, combs, and manicure and pedicure tools. The market's growth is driven by…
More Releases for Myocardial
Myocardial Infarction Drugs Market
According to a new report published by Allied Market Research, titled, "Myocardial Infarction Drugs Market by Product Type (Analgesics, Antiplatelet Agents, Vasodilators, Thrombolytics, Anti-Thrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, ' Adrenergic Blockers, Angiotensin Receptor Blockers, and Angiotensin Converting Enzyme Inhibitors) and by Distribution Channel (Hospital Pharmacies, Hospitals, Drug Stores, and Online Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2019-2026".
The Global market size of Myocardial Infarction Drugs Market was $XX…
Post-Myocardial Infarction Market rake higher revenue in 2025
Global Post-Myocardial Infarction Market: Overview
The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are…
Post-Myocardial Infarction Market Foretell Optimal Growth by 2025
Global Post-Myocardial Infarction Market: Overview
The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are…
Myocardial Ischemia Market to Record Ascending Growth
Myocardial ischemia is characterized by a specific condition, where there is an insufficient flow of blood to the heart muscle (myocardium) through coronary arteries. Due to an obstruction or constriction of the arteries, the heart is not able to pump oxygenated blood and other vital nutrients to the body efficiently and finally leads to destruction of the heart muscles. Blockage of an artery (due to atherosclerotic plaque), blood clots, heart…
Post-Myocardial Infarction Market - Vendor Landscape & Forecast 2017 - 2025
Global Post-Myocardial Infarction Market: Overview
The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are…
Myocardial Ischemia - Pipeline Review, H1 2017
MarketResearchReports.Biz presents this most up-to-date research on "Myocardial Ischemia - Pipeline Review, H1 2017"
Description
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Ischemia - Pipeline Review, H1 2017, provides an overview of the Myocardial Ischemia (Cardiovascular) pipeline landscape.
Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side…
